A Single-Center Analysis of Sentinel Node Biopsy for Male Breast Cancer

Bibliographic Information

Other Title
  • 男性乳癌におけるセンチネルリンパ節生検(SNB)の検討

Search this article

Description

Purpose: Sentinel node biopsy (SNB) is a standard treatment procedure for female breast cancer. However, the utility of SNB for male breast cancer (MBC) has not been established; therefore, this topic was the focus of our study.<BR>Patients and Methods: Six patients with MBC underwent SNB using dye alone. The mean age of the patients was 69 years and patients were clinical stage was I or ⅡA. Sentinel node (SN)-negative patients were followed without axillary lymph node dissection (ALND). The median follow-up term was 60 months.<BR>Results: SNs were detected in 6 patients (100%). One patient was SN-positive (16.7%), and underwent ALND. No patient had adverse events due to the dye injection and there was no arm lymphedema in patients who did not undergo ALND. Two (40%) of the remaining 5 patients who did not undergo ALND had axillary lymph node (ALN) relapse and subsequently underwent salvage ALND. No patients relapsed at distant sites. At present, 5 patients are alive, and one died from an unrelated disease.<BR>Conclusion: Intensive follow-up is needed after SNB without ALND in MBC because of the high rate of ALN relapse.

Journal

References(19)*help

See more

Details 詳細情報について

Report a problem

Back to top